Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

VIVO Cannabis Inc. (VIVO.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.04500.0000 (0.00%)
At close: 02:09PM EDT
Advertisement
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0450
Open0.0500
Bid0.0450 x N/A
Ask0.0500 x N/A
Day's Range0.0500 - 0.0500
52 Week Range0.0400 - 0.1350
Volume131,841
Avg. Volume171,007
Market Cap16.69M
Beta (5Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)-0.1900
Earnings DateMay 16, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for VIVO.TO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      VIVO Cannabis Announces Canna Farms Granted Research Licence by Health Canada

      Toronto, Ontario--(Newsfile Corp. - July 22, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licences under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced that Canna Farms has received a Research Licence from Health Canada allowing it to possess cannabis for the purpose of research. The Research

    • Newsfile

      VIVO Cannabis Announces Results of 2022 AGM and Election of New Directors

      Toronto, Ontario--(Newsfile Corp. - July 2, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQB: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, is pleased to announce the results of its annual general and special meeting of shareholders held today (the "Meeting"). As announced this morning, at the Meeting, shareholders approved fixing the number of directors at five, and the election of Ray Laflamme, Glen Huber, Shai Altman, Eric ...

    • Newsfile

      VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric Research: Anxiety & Depression Outcomes in Medical Cannabis Patients

      Toronto, Ontario--(Newsfile Corp. - June 3, 2022) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of medical cannabis products and patient services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms"), ABcann Medicinals Inc., today announced results from its first study investigating how medical cannabis impacts anxiety and depression outcomes. The publication, entitled "Medical can

    Advertisement
    Advertisement